Sanofi’s Tzield has been accepted for priority review by the U.S. Food and Drug Administration to expand its use to children aged one year and older with stage 2 type 1 diabetes. The submission is ...
(PRESS RELEASE) HELSINKI, 5-Jan-2026 — / EuropaWire / — Hiab has completed the acquisition of ING Cranes, a Brazilian manufacturer of loader cranes, following the transaction announced in November ...